Brief: Biosyent Q2 fully diluted EPS $0.07
12/08/2016 13:01
Aug 12 (Reuters) - Biosyent Inc RX.V :
* Q2 2016 net revenues of $4.4 million, up 22% versus Q2
2015
* Biosyent Inc says Q2 fully diluted EPS was $0.07
Source text for Eikon: ID:nMKWjRWywa
Further company coverage: RX.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid